Myristoylated Alanine-Rich Protein Kinase C Substrate (MARCKS) (N-Term) Peptide
-
- Target See all MARCKS products
- MARCKS (Myristoylated Alanine-Rich Protein Kinase C Substrate (MARCKS))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GEAAVASSPS KANGQENGHV KVNGDASPAA AESGAKEELQ ANGSAPAADK
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- MARCKS Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MARCKS (Myristoylated Alanine-Rich Protein Kinase C Substrate (MARCKS))
- Background
-
The protein encoded by this gene is a substrate for protein kinase C. It is localized to the plasma membrane and is an actin filament crosslinking protein. Phosphorylation by protein kinase C or binding to calcium-calmodulin inhibits its association with actin and with the plasma membrane, leading to its presence in the cytoplasm. The protein is thought to be involved in cell motility, phagocytosis, membrane trafficking and mitogenesis.
Alias Symbols: MACS, 80K-L, PKCSL, PRKCSL
Protein Size: 332 - Gene ID
- 4082
- NCBI Accession
- NM_002356, NP_002347
- UniProt
- P29966
-